April 3 (Reuters) - Pfizer Inc is in talks withProcter & Gamble Co for a sale of the largest
The companies were far apart on a price for the business andPfizer is considering other options, including a joint venturewith other drugmakers, the report said.
Pfizer said it is evaluating potential strategic options forthe unit and expects to make a decision in 2018.
GlaxoSmithKline, Reckitt Benckiser andJohnson & Johnson have all exited from the biddingprocess, endangering an auction Pfizer hoped would bring in asmuch as
P&G said it declined to comment.(Reporting by Manas Mishra in Bengaluru; Editing by SrirajKalluvila)